<DOC>
	<DOCNO>NCT00219284</DOCNO>
	<brief_summary>To assess motor function quality life ( QoL ) Parkinson 's disease ( PD ) subject end-of-dose wearing , compare immediate delay switch carbidopa/levodopa entacapone .</brief_summary>
	<brief_title>Effects Carbidopa/Levodopa/Entacapone Motor Function Quality Life Patients With Parkinson 's Disease</brief_title>
	<detailed_description>This prospective , multi-center , randomize , open-label study blind raters evaluate effect immediate versus delay switch carbidopa/levodopa/entacapone motor function quality life patient Parkinson 's disease end-of-dose wearing .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Carbidopa , levodopa drug combination</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<mesh_term>Entacapone</mesh_term>
	<criteria>Males female 3080 year age ( inclusive ) . Patients aged 8185 year eligible participate principal investigator consider patient otherwise good health . Clinical diagnosis Parkinson 's disease exhibit two three symptom ( rigidity , rest tremor , bradykinesia ) . All patient require endof dose wearing ( EODWO , reemergence PD symptom end least two daily dos levodopa wake hour ) . Taking regular dos immediate release carbidopa/levodopa Unstable Parkinson 's Disease require booster dos treatment need dose regimen levodopa Female subject pregnant , try become pregnant nursing infant Other protocoldefined inclusion/exclusion criterion apply study .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Parkinson 's disease , tremor</keyword>
</DOC>